Ahzantive Injection, Solution
NDC Package 85006-2908-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ahzantive (aflibercept-mrbb) injection is 4. This formulation utilizes a injection, solution delivery system. Marketed by Valorum Biologics, Llc, this product is identified by NDC 85006-2908 and is authorized under FDA application BLA761378.

Identification & Billing

NDC Package Code
85006-2908-1
Package Description
.05 mL in 1 VIAL, SINGLE-DOSE
Product Code
85006-2908
11-Digit Billing Format
85006290801
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ahzantive
Non-Proprietary Name
Aflibercept-mrbb
Substance Name
Aflibercept-mrbb
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravitreal - Administration within the vitreous body of the eye.
Active Ingredient(s)
AFLIBERCEPT-MRBB 40 mg/mL
Pharmacologic Class
Usage Information
4. CONTRAINDICATIONS4.1 Ocular or Periocular InfectionsAHZANTIVE is contraindicated in patients with ocular or periocular infections.4.2 Active Intraocular InflammationAHZANTIVE is contraindicated in patients with active intraocular inflammation.4.3 HypersensitivityAHZANTIVE is contraindicated in patients with known hypersensitivity to aflibercept or any of the excipients in AHZANTIVE. Hypersensitivity reactions may manifest as rash, pruritus, urticaria, severe anaphylactic/anaphylactoid reactions, or severe intraocular inflammation.

Regulatory & Marketing

Labeler Name
Valorum Biologics, Llc
Product Type
Human Prescription Drug
FDA Application #
BLA761378
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
06-01-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85006-2908-1 identifies a specific commercial package of .05 ml in 1 vial, single-dose of Ahzantive, a human prescription drug labeled by Valorum Biologics, Llc. This injection, solution is formulated for intravitreal use and contains aflibercept-mrbb as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Valorum Biologics, Llc on June 01, 2024. The current certification is valid through December 31, 2026.

How is this Valorum Biologics, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85006290801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
85006-2908-1
11-Digit CMS (5-4-2)
85006-2908-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.